Skip to main content

Harvard Bioscience Inc

HBIO
Exchange
Nasdaq
Industry
Laboratory Analytical Instruments
SEC CIK
0001123494

No open-market purchases or sales by Harvard Bioscience Inc insiders were filed in the last 90 days; 37 institutions reported holding it in 13F filings for Q2 2026, worth $10.3M in total; no superinvestor holds it.

13F holders, Q2 2025

Institutional positions in Harvard Bioscience Inc as of Jun 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
69
−23 vs. Q1 2025
Shares held
18.9M
−6.73M (−26.2%) vs. Q1 2025
Total value
$8.39M
−$6.12M (−42.2%) vs. Q1 2025
New holders
14
19 more added
Sold out
37
27 more reduced

Compare with Q1 2025: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting HBIO on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ2 2025: 69 institutions
Q1 2021: 87 institutionsQ2 2021: 99 institutionsQ3 2021: 99 institutionsQ4 2021: 103 institutionsQ1 2022: 98 institutionsQ2 2022: 91 institutionsQ3 2022: 79 institutionsQ4 2022: 68 institutionsQ1 2023: 66 institutionsQ2 2023: 100 institutionsQ3 2023: 94 institutionsQ4 2023: 93 institutionsQ1 2024: 90 institutionsQ2 2024: 100 institutionsQ3 2024: 95 institutionsQ4 2024: 96 institutionsQ1 2025: 92 institutionsQ2 2025: 69 institutionsQ3 2025: 61 institutionsQ4 2025: 64 institutionsQ1 2026: 37 institutionsQ2 2026: 37 institutions
Value heldQ2 2025: $8.39M
Q1 2021: $144.2MQ2 2021: $232.3MQ3 2021: $191.7MQ4 2021: $211.4MQ1 2022: $187.3MQ2 2022: $106.8MQ3 2022: $74.0MQ4 2022: $83.3MQ1 2023: $127.2MQ2 2023: $178.2MQ3 2023: $141.6MQ4 2023: $176.4MQ1 2024: $137.8MQ2 2024: $90.7MQ3 2024: $84.2MQ4 2024: $65.5MQ1 2025: $14.5MQ2 2025: $8.39MQ3 2025: $7.29MQ4 2025: $11.7MQ1 2026: $7.73MQ2 2026: $10.3M
Institutions holding HBIO and their total value by quarter
QuarterHoldersValue
Q2 202637$10.3M
Q1 202637$7.73M
Q4 202564$11.7M
Q3 202561$7.29M
Q2 202569$8.39M
Q1 202592$14.5M
Q4 202496$65.5M
Q3 202495$84.2M
Q2 2024100$90.7M
Q1 202490$137.8M
Q4 202393$176.4M
Q3 202394$141.6M
Q2 2023100$178.2M
Q1 202366$127.2M
Q4 202268$83.3M
Q3 202279$74.0M
Q2 202291$106.8M
Q1 202298$187.3M
Q4 2021103$211.4M
Q3 202199$191.7M
Q2 202199$232.3M
Q1 202187$144.2M

Institutions, Q2 2025

Shares, value and share of portfolio for each institution holding Harvard Bioscience Inc; share changes are against Q1 2025.

Institutions holding HBIO in Q2 2025
InstitutionSharesValue% of portfolioChange in sharesAction
Amalgamated Bank0$00.00%−1,319−100.0%Sold out
Sterling Capital Management LLC0$00.00%−532−100.0%Sold out
Russell Investments Group, Ltd.0$00.00%−306−100.0%Sold out
True Wealth Design, LLC0$00.00%−56−100.0%Sold out
IFP Advisors, Inc0$00.00%−15−100.0%Sold out
Avion Wealth0$00.00%−235−100.0%Sold out